Publicacions en què col·labora amb FEDERICO GILBERTO HAWKINS CARRANZA (266)

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

2021

  1. Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly

    Clinical Endocrinology, Vol. 95, Núm. 1, pp. 58-64

2020

  1. Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer

    Medical sciences (Basel, Switzerland), Vol. 8, Núm. 4

  2. Corrigendum to: Expanding the phenotype of biallelic RNPC3 variants associated with growth hormone deficiency (American Journal of Medical Genetics Part A, (2020), 182, 8, (1952-1956), 10.1002/ajmg.a.61632)

    EMBO Molecular Medicine

  3. Ethnicity Strongly Influences Body Fat Distribution Determining Serum Adipokine Profile and Metabolic Derangement in Childhood Obesity

    Frontiers in Pediatrics, Vol. 8

  4. Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 521-530

  5. Senile and Postmenopausal Osteoporosis: Pathophysiology, Diagnosis, and Treatment

    Endocrinology of Aging: Clinical Aspects in Diagrams and Images (Elsevier), pp. 131-169

  6. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy

    Cancer Medicine, Vol. 9, Núm. 16, pp. 5746-5755

2019

  1. Different development of serum sclerostin compared to other bone remodeling markers in the first year after a liver transplant

    Revista de Osteoporosis y Metabolismo Mineral

  2. Enfermedad metabólica ósea postrasplante

    Anales de la Real Academia Nacional de Medicina, Núm. 136, pp. 249-255

  3. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911

  4. Trabecular bone score and bone mineral density in patients with postsurgical hypoparathyroidism after total thyroidectomy for differentiated thyroid carcinoma

    Surgery (United States), Vol. 165, Núm. 4, pp. 814-819

2018

  1. Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial

    JAMA - Journal of the American Medical Association, Vol. 319, Núm. 1, pp. 38-48

  2. Farmacología del calcio y del hueso

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 647-656

  3. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy

    Endocrine, Vol. 62, Núm. 1, pp. 166-173

  4. Response to growth hormone in patients with RNPC3 mutations

    EMBO Molecular Medicine

  5. RhIGF-1 Treatment Increases Bone Mineral Density and Trabecular Bone Structure in Children with PAPP-A2 Deficiency

    Hormone Research in Paediatrics, Vol. 89, Núm. 3, pp. 200-204

2017

  1. Erdheim-Chester Disease: Case Report With Multisystemic Involvement, Including Diabetes Insipidus And Hypogonadism

    AACE Clinical Case Reports, Vol. 3, Núm. 2, pp. e111-e115

  2. Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial

    Maternal and Child Nutrition, Vol. 13, Núm. 3

  3. Thyroid hormones, TSH, thyroid cancer and bones in pre- and postmenopausal women

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 9, Núm. 2, pp. 89-101